U.S. FDA approves J&J hepatitis C pill
(Reuters) - U.S. regulators on Friday approved the use of Johnson & Johnson's Olysio, also known as simeprevir, as a treatment for chronic infection w...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/UmNLO7MsZEM/story01.htm
No comments:
Post a Comment